GEHC vs BSX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
GEHC · GE HealthCare Technologies$82.38 ▼ 1.64%
BSX · Boston Scientific$42.75 ▼ 4.23%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- GEHC +12.3%
- BSX -57.6%
Head to head
| Metric | GEHC | BSX |
|---|---|---|
| Price | $82.38 | $42.75 |
| Change today | ▼ 1.64% | ▼ 4.23% |
| Market cap | $37.25B | $61.96B |
| Return, 3 months | +12.9% | -15.3% |
| Return, year to date | +0.6% | -55.2% |
| Return, 1 year | +12.9% | -57.3% |
| P/E (TTM) | 17.4 | 18.0 |
| P/B | 3.2 | 2.4 |
| P/E percentile vs own 5y | 43rd | 1st |
| Dividend yield | 0.17% | – |
| Revenue growth (YoY, latest qtr) | +7.2% | +1.4% |
| Net profit growth (YoY) | +34.3% | -23.2% |
| Gross margin | 39.9% | 69.1% |
| Operating margin | 13.3% | 20.6% |
| Net margin | 10.0% | 16.6% |
| Return on equity | 19.9% | – |
| Analyst target vs. price | +2.4% | +17.1% |
| Analyst buy share | 62% | 64% |
| RSI (14) | 72 | 45 |
| 30-day volatility | 36.0% | 38.7% |
| Max drawdown, 1 year | -32.5% | -60.4% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BSX is the largest of the group by market value.
- GEHC has returned the most over the past year.
- GEHC carries the lowest trailing P/E.
- GEHC is growing revenue fastest.
- BSX keeps the most profit per dollar of sales.
- GEHC has been the calmest stock over the last 30 days.